Clinical Trial Update: Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan [Phase 3]

View source ↗

Summary

This document reports the completion of a long-term extension Phase 3 trial evaluating eptinezumab as a preventive treatment for migraine in Japanese participan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• VYEPTI (eptinezumab)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Migraine | Phase 3 | Status: COMPLETED